教員検索

神野　康弘 (じんの　やすひろ) 　／　Yasuhiro Jinno

高齢化社会が急速に進む日本において、健康年齢を延長することは健康保険基金の存続に重要な要因といえます。健康年齢延長に関しては、従前の健診データの利活用で新たな生活スタイルや健康増進因子を見出すことには大きな意義があると考えます。都道府県別の病院数や病床数との関係、透析患者の年別発症数と食事との関係、その他、成人病疾患に関する原因因子の特定などの新しい健康増進因子を探索すべく様々な疫学的データにアクセスし解析し新たな所見を見出し、国民の健康や福祉に貢献していきます。

詳しくは研究室のホームページをご覧ください

所属	薬学部薬学科教授薬学研究科薬学専攻教授
学位	博士（薬学）　 ( 名古屋市立大学 1994年 2月 )
専門分野	社会薬学、薬理学

学歴・職歴	1988年 3月名古屋市立大学薬学部博士課程前期修了 1988年 4月キリンビール株式会社　医薬探索研究所　研究員 2012年 4月協和発酵キリン株式会社　薬事監査部長 2020年 4月国際医療福祉大学　福岡薬学部　教授 2021年 10月東京大学医学部研究倫理支援室　特任研究員 2024年 4月千葉科学大学　薬学部　教授
主な担当科目【学部】	医療人の使命、医療コミュニケーション、基礎薬学演習
主な論文・著書	1．The significant association between health examination results and population health: A cross-sectional ecological study using a nation-wide health check-up database in Japan. Yukinori Nagakura, Hideaki Kato, Satoshi Asano, Yasuhiro Jinno, Shigeharu Tanei International Journal of Environmental Research and Public Health 18 836-849 2021 2．Effects of the;K;channel opener KR;on the cardiovascular metabolic syndrome model in rats Okada Y, Yoshino T, Takeuchi A, Endoh M, Ohta H, Jinno Y, Yokoyama T, Izawa T J Cardiovasc Pharmacol 35 287-293 2000 3．Protective Effect of the K+ Channel Opener KRN4884 on Peripheral Occlusive Arterial Disease in Rats. T Yoshino, H Ohta, Y Jinno, Y Torii, N Ogawa, T Izawa Y, Okada Gen Pharmacol 31 59-62 1998 4．KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs. Kawahara J, Jinno Y, Endo M, Izumi H, Takeuchi A, Izawa T J Cardiovasc Pharmacol 29 814-819 1997 5．Effect of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with Levcromakalim, Nilvadipine and Nifedipine. H Izumi, Y Jinno, S Kaneta, Y Tanaka, Y Okada, T Izawa, N Ogawa J Cardiovasc Pharmacol 26 189-197 1995 6．Effect of KRN2391 on canine ventricular arrhythmia models. Takeuchi A, Harada K, Miwa A, Jinno Y, Kaneta S, Yokoyama T, Ogawa N Gen Pharmacol 25 53-60 1994 7．Pharmacological analysis of the effect of KRN2391 on coronary vasculature in perfused rat heart. Miwa A, Jinno Y, Yokoyama T, Izawa T, Ogawa N Gen Pharmacol 25 471-474 1994 8．Pharmacological analysis of the inhibitory effects of KRN2391 on endothelin-1-induced contraction in isolated large coronary artery of the pig. Harada K, Miwa A, Yokoyama T, Izawa T, Ogawa N, Jinno Y Gen Pharmacol 25 935-939 1994 9．Comparative analysis of vasodilating mechanisms of Ki1769, Ki3315 and KRN2391, Yokoyama T, Okada Y, Jinno Y, Izumi H, Izawa T, Ogawa N Gen Pharmacol 25 941-945 1994 10．Comparison of the effects of KRN2391 and other coronary dilators on porcine isolated coronary arteries of different sizes. Kasai H, Jinno Y, Kaneta S, Fukata Y, Fukushima H, Ogawa N J Pharm Pharmacol 45 573-575 1993 11．Effect of KRN2391 on venous return: comparison with other vasodilators. Kaneta S, Jinno Y, Miwa A, Fukushima H, Ogawa N J Cardiovasc Pharmacol 22 82-88 1993 12．Vasorelaxant action of Ki1769, a new pyridinecarboximidamide, in isolated porcine coronary artery. Okada Y, Yokoyama T, Jinno Y, Kashiwabara T, Izawa T, Fukushima H, Ogawa N Eur J Pharmacol 241 177-181 1993 13．Effect of KRN2391, a novel vasodilator, on endothelin-1-induced contraction of porcine coronary artery: comparison with cromakalim, nitroglycerin and nifedipine. Miwa A, Kasai H, Motoki K, Jinno Y, Yokoyama T, Fukushima H, Ogawa N Arch Int Pharmacodyn Ther 326 52-61 1993 14．Hemodynamic Profile of KRN2391, a novel vasodilator, in anesthetized dogs. Ogawa N, Jinno Y, Kaneta S, Harada K, Fukata Y, Fukushima H J Cardiovasc Pharmacol 21 874-882 1993 15．Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes. A Miwa, S Kaneta, K Motoki, Y Jinno, H Kasai, Y Okada, H Fukushima, N Ogawa Br J Pharmacol 109 632-636 1993 16．Mechanism of Action of KRN2391, a Novel Vasodilator, in Canine Mesenteric Artery. N Ogawa, Y Fukata, S Kaneta, Y Jinno, A Miwa H Fukushima Japan J Pharmacol 61 303-30 1993 17．Mechanism of Action of KRN2391 in Canine Coronary Vascular Bed. N Ogawa, Y Fukata, S Kaneta, Y Jinno, A Miwa H Fukushima Japan J Pharmacol 63 305-311 1993 18．Effects of K + channel openers on ischemic dysfunction and metabolic disturbance in isolated perfused rat heart. H. Ohta, H. Nakazawa, Y. Jinno, K. Harada, N. Ogawa, A. Miwa, K. Nishikori Eur J Phamacol 231 323-330 1993 19．Comparison of the anti-vasoconstrictor effects of a novel vasodilator KRN2391, nicorandil and nifedipine on isolated porcine large coronary artery. H. Kasai, Y. Jinno, S, Kaneta, T. Tanaka, H. Fukushima, T. Izawa, N. Ogawa Arch Int Pharmacodyn Ther 321: 63-71 1993 20．Inotropic and chronotropic effects of KRN2391, a novel vasodilator, on isolated guinea-pig. Y. Jinno, S. Kaneta, H. Ohta, H. Fukushima, T. Izawa, N. Ogawa Asia Pacific J Pharmacol 8 23-27 1993 21．Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide. J Cardiovasc Pharmacol. Ogawa N, Fukata Y, Kaneta S, Jinno Y, Fukushima H, Nishikori K J Cardiovasc Pharmacol 20 11-17 1992 22．Tolerance to the increase in coronary blood flow induced by KRN2391. Kaneta S, Jinno Y, Harada K, Fukushima H, Ogawa N Arch Int Pharmacodyn Ther 318 21-35 1992 23．Comparative cardiovascular effects of KRN2391 and other coronary vasodilators in anesthetized open-chest dogs. Ogawa N, Kaneta S, Jinno Y, Kasai H, Nishikori K, Fukushima H Arch Int Pharmacodyn Ther 318 36-46 1992 24．Contribution of cyclic GMP formation to KRN2391-induced relaxation in porcine coronary artery of the pig. Y. Jinno, H. Kasai, H. Ohta, K. Nishikori, H. Fukushima, N. Ogawa Br. J . Pharmacol 106 906-909 1992 25．Contribution of cyclic GMP formation to KRN2391-induced relaxation in porcine coronary artery of the pig. Y. Jinno, H. Kasai, H. Ohta, K. Nishikori, H. Fukushima, N. Ogawa Br. J . Pharmacol 106 906-909 1992 26．Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart. H. Ohta, Y. Jinno, K. Harada, N. Ogawa, H. Fukushima, K. Nishikori Eur J PharmacoI 204 171-177 1991
所属学会	日本薬理学会　学術評議員日本社会薬学会レギュラトリーサイエンス学会
資格	薬剤師第一種放射線取扱主任者キャリアコンサルタント ISO9001　QMS監査員

page top